Continuing our investigation into medical research careers, we interviewed Prof. Andrew McMichael. Andrew is Director of the Weatherall Institute of Molecular Medicine in Oxford, and focuses especially on two areas of special interest to us: HIV and flu vaccines.
Key points made
- Andrew would recommend starting in medicine for the increased security, better earnings, broader perspective and greater set of opportunities at the end. The main cost is that it takes about 5 years longer.
- In the medicine career track, you qualify as a doctor in 5-6 years, then you work as a junior doctor for 3-5 years, while starting a PhD. During this time, you start to move towards a promising speciality, where you build your career.
- In the biology career track, get a good undergraduate degree, then do a PhD. It’s very important to join a top lab and publish early in your career. Then you can start to move towards an interesting area.
- After you finish your PhD is a good time to reassess. It’s a competitive career, and if you’re not headed towards the top, be prepared to do something else. Public health is a common backup option, which can make a significant contribution. If you’ve studied medicine, you can do that. People sometimes get stranded mid-career, and that can be tough.
- An outstanding post-doc applicant has a great reference from their PhD supervisor, is good at statistics/maths/programming, and has published in a top journal.
- If you qualify in medicine in the UK, you can earn as much as ordinary doctors while doing your research, though you’ll miss out on private practice. In the US, you’ll earn less.
- Some exciting areas right now include stem cell research, neuroscience, psychiatry and the HIV vaccine.
- To increase your impact, work on good quality basic science, but keep an eye out for applications.
- Programming, mathematics and statistics are all valuable skills. Other skills shortages develop from the introduction of new technologies.
- Good researchers can normally get funded, and Andrew would probably prefer a good researcher to a half million pound grant, though he wasn’t sure.
- He doesn’t think that bad methodology or publication bias is a significant problem in basic science, though it might be in clinical trials.